Browsing QU Health Research by Subject "targeted cancer immunotherapy"
Now showing items 1-1 of 1
-
Novel SPEA Superantigen Peptide Agonists and Peptide Agonist-TGFαL3 Conjugate. In Vitro Study of Their Growth-Inhibitory Effects for Targeted Cancer Immunotherapy
( Multidisciplinary Digital Publishing Institute (MDPI) , 2023 , Article)Bacterial superantigens (SAgs) are effective T-cell stimulatory molecules that lead to massive cytokine production. Superantigens crosslink between MHC class II molecules on the Antigen Presenting Cells (APC) and TCR on ...